Literature DB >> 32178949

Medication-related osteonecrosis of the jaw (MRONJ) stage III: Conservative and conservative surgical approaches versus an aggressive surgical intervention: A systematic review.

Jasper Vanpoecke1, Laurence Verstraete2, Maximiliaan Smeets3, Joël Ferri4, Romain Nicot5, Constantinus Politis6.   

Abstract

Entities:  

Keywords:  Jaw; MRONJ; Osteonecrosis; Surgery

Mesh：

Substances：

Year:  2020        PMID： 32178949     DOI： 10.1016/j.jcms.2020.02.017

Source DB:  PubMed          Journal:  J Craniomaxillofac Surg        ISSN： 1010-5182            Impact factor:   2.078


× No keyword cloud information.
  8 in total

1.  Nonexposed antiresorptive agent-related osteomyelitis of the jaw: a single-center cohort study.

Authors:  Takuma Watanabe; Takeshi Yoshida; Sachi Akizuki; Shigeki Yamanaka; Kazumasa Nakao; Shizuko Fukuhara; Keita Asai; Ryuji Uozumi; Kazuhisa Bessho
Journal:  J Bone Miner Metab       Date:  2022-05-09       Impact factor: 2.626

2.  Analysis of medication-related osteonecrosis of the jaw with bone SPECT/CT: relationship between patient characteristics and maximum standardized uptake value.

Authors:  Ruri Ogawa; Ichiro Ogura
Journal:  Dentomaxillofac Radiol       Date:  2021-05-21       Impact factor: 2.419

Review 3.  The preventive care of medication-related osteonecrosis of the jaw (MRONJ): a position paper by Italian experts for dental hygienists.

Authors:  Rodolfo Mauceri; Rita Coniglio; Antonia Abbinante; Paola Carcieri; Domenico Tomassi; Vera Panzarella; Olga Di Fede; Francesco Bertoldo; Vittorio Fusco; Alberto Bedogni; Giuseppina Campisi
Journal:  Support Care Cancer       Date:  2022-03-16       Impact factor: 3.359

4.  Effectiveness of surgery and hyperbaric oxygen for antiresorptive agent-related osteonecrosis of the jaw: A subgroup analysis by disease stage.

Authors:  Takuma Watanabe; Keita Asai; Shizuko Fukuhara; Ryuji Uozumi; Kazuhisa Bessho
Journal:  PLoS One       Date:  2021-01-04       Impact factor: 3.240

Review 5.  Various Therapeutic Methods for the Treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ) and Their Limitations: A Narrative Review on New Molecular and Cellular Therapeutic Approaches.

Authors:  Sung-Woon On; Seoung-Won Cho; Soo-Hwan Byun; Byoung-Eun Yang
Journal:  Antioxidants (Basel)       Date:  2021-04-27

6.  18F-Fluoride PET/CT Imaging of Medication-Related Osteonecrosis of the Jaw in Conservative Treatment-A Case Report.

Authors:  Christian Philipp Reinert; Christina Pfannenberg; Sergios Gatidis; Christian la Fougère; Konstantin Nikolaou; Sebastian Hoefert
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

7.  Combined approach to treatment of advanced stages of medication-related osteonecrosis of the jaw patients.

Authors:  Onur Şahin; Ender Akan; Birkan Tatar; Ceren Ekmekcioğlu; Nuri Ünal; Onur Odabaşı
Journal:  Braz J Otorhinolaryngol       Date:  2021-05-06

8.  Patients' quality of life improves after surgical intervention of stage III medication-related osteonecrosis of the jaw.

Authors:  Stefan Moll; Steffen Mueller; Johannes K Meier; Torsten E Reichert; Tobias Ettl; Christoph Klingelhöffer
Journal:  Oral Maxillofac Surg       Date:  2020-11-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.